Other

Temporary Equity, Accretion to Redemption Value, Adjustment

CRH Temporary Equity, Accretion to Redemption Value, Adjustment remained flat by 0.0% to $7.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $7.00M to $7.00M. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementIncome Statement
SectionOther
CategoryRisk
SignalLower is better
VolatilityModerate
First reportedQ1 2023
Last reportedQ1 2026Apr 30, 2026

How to read this metric

Large adjustments can significantly impact net income available to common shareholders, even if they do not reflect operational cash flows.

Detailed definition

Represents the periodic adjustment to the carrying amount of equity instruments that are redeemable at the option of the...

Peer comparison

Specific to companies with complex capital structures involving redeemable non-controlling interests or preferred equity.

Metric ID: other_temporary_equity_accretion_to_redemption_value_adjustment

Historical Data

10 periods
 Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value$10.00M$2.00M$6.00M$4.00M$3.00M$23.00M$7.00M$6.00M$7.00M$7.00M
QoQ Change-80.0%+200.0%-33.3%-25.0%+666.7%-69.6%-14.3%+16.7%+0.0%
YoY Change-60.0%+50.0%+283.3%+75.0%+100.0%-69.6%+0.0%
Range$2.00M$23.00M
CAGR-14.7%
Avg YoY Growth+54.1%
Median YoY Growth+50.0%
Current Streak2 quarters growth

Frequently Asked Questions

What is CRH's temporary equity, accretion to redemption value, adjustment?
CRH (CRH) reported temporary equity, accretion to redemption value, adjustment of $7.00M in Q1 2026.
How has CRH's temporary equity, accretion to redemption value, adjustment changed year-over-year?
CRH's temporary equity, accretion to redemption value, adjustment decreased by 0.0% year-over-year, from $7.00M to $7.00M.
What does temporary equity, accretion to redemption value, adjustment mean?
Adjustments made to the value of redeemable equity to reflect what the company would owe if the equity were redeemed today.